The Hill The U.S. will participate in the World Health Organization’s (WHO) upcoming meeting on the composition of the influenza vaccine despite officially withdrawing from the global group last month.
The WHO will meet on Feb. 26 in Turkey to discuss the composition of the 2026-2027 flu vaccine for the northern hemisphere. “The vaccine composition meeting will be taking place later this month. The U.S. will participate in that meeting as far as I understand,” Maria Van Kerkhove, interim director of the WHO’s Department of Epidemic and Pandemic Management, said in a press conference Wednesday.
Last month, the U.S. officially withdrew from the WHO following the end of the year-long process to exit the group. The U.S. was a founding member of the WHO and had been part of the organization for nearly 80 years.